Everything is Bigger in Texas...Including Medicaid

Medicaid enrollment has climbed by 80,000 in Texas despite the state opting out of Medicaid expansion.

Jul 20, 2014 at 1:00PM

Despite choosing not to embrace Medicaid expansion, more than 80,000 Texans have enrolled in the government program thanks to increased awareness following the launch of Obamacare exchanges launch last fall.

The jump in enrollment presents a problem for states like Texas that opted against bumping up eligibility because it increases the amount the state will spend on the program, but it's good news for Centene (NYSE:CNC) and Molina (NYSE:MOH), two companies that help run the state's Medicaid program.


Source: Governor of Texas Flickr

First, a bit of background
Initially, the Affordable Care Act's Medicaid expansion provision effectively increased eligibility to 138% of the Federal poverty level nationwide, or roughly $33,000 for a family of four. For those that were found newly eligible, the Federal government agreed to pay 100% of the cost of care initially and no less than 90% of costs in the future, with the states picking up the rest.

However, the Supreme Court gave states the option not to expand their program in 2012 and as a result; just 26 states opted to increase coverage.

Even though a significant number of states didn't expand (including Texas), Medicaid has still proven widely successful at signing up new members nationwide.

According to the Centers for Medicare and Medicaid Services, more than 6 million people have enrolled in Medicaid since last summer, including 725,000 members in non-expansion states like Texas. That means that private Medicaid insurers that are running plans in states that didn't expand Medicaid are still getting a windfall.


Source: Centene Corp.

Surging demand
Centene's biggest markets opted out of Medicaid expansion, including Texas, where Centene serves 900,000 members and Florida, where Centene serves 230,000 members.

But even though so much of Centene's business comes from these non-expansion states, Centene revenue is jumping.

The company serves nearly 2.9 million people who participate in government funded programs like Medicaid and CHIP, and a 13% jump in membership in the first quarter resulted in Centene's sales growing by a third to $3.46 billion in the first quarter.

Molina Healthcare's Medicaid business is humming too. Molina serves 2.1 million members including 246,000 in Texas, but it's less reliant on non-expansion states for growth. That's because Molina does a lot of business in California, a state that embraced expansion and has seen Medicaid applications soar.

In the first quarter, California accounted for 47,000 of Molina's 133,000 new Medicaid members and those new members helped Molina's revenue climb 21% to $2.1 billion.

Although Medicaid insurers like Centene and Molina have smaller margins than larger, more diversified insurers that serve commercial customers, rising revenue has both companies expecting to post significant earnings growth this year. Centene expects its EPS will reach between $3.60 and $3.90 this year, up from $2.87 last year, and Molina is guiding investors to expect EPS of between $4 and $4.50 this year, up from $3.13 in 2013.

Fool-worthy final thoughts
Kaiser estimates that as many as one million Medicaid applications nationwide have yet to be processed, so there's likely to be additional membership growth in the third quarter too.

But growth over the coming year won't just come from expansion states. Kaiser reports that roughly 875,000 Texans qualify for Medicaid but haven't yet signed up for the program.

Centene will release its second quarter results on July 22nd and Molina will update investors with its second quarter numbers on July 30th, so investors won't have to wait long to find out whether rising membership drove profits again last quarter, but given the numbers we're seeing out of states like Texas, it wouldn't surprise me if both companies posted solid results.

Leaked: This coming blockbuster will revolutionize health care way beyond Texas
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Todd Campbell owns shares of Molina Healthcare and Centene Corp. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

A Financial Plan on an Index Card

Keeping it simple.

Aug 7, 2015 at 11:26AM

Two years ago, University of Chicago professor Harold Pollack wrote his entire financial plan on an index card.

It blew up. People loved the idea. Financial advice is often intentionally complicated. Obscurity lets advisors charge higher fees. But the most important parts are painfully simple. Here's how Pollack put it:

The card came out of chat I had regarding what I view as the financial industry's basic dilemma: The best investment advice fits on an index card. A commenter asked for the actual index card. Although I was originally speaking in metaphor, I grabbed a pen and one of my daughter's note cards, scribbled this out in maybe three minutes, snapped a picture with my iPhone, and the rest was history.

More advisors and investors caught onto the idea and started writing their own financial plans on a single index card.

I love the exercise, because it makes you think about what's important and forces you to be succinct.

So, here's my index-card financial plan:


Everything else is details. 

Something big just happened

I don't know about you, but I always pay attention when one of the best growth investors in the world gives me a stock tip. Motley Fool co-founder David Gardner (whose growth-stock newsletter was rated #1 in the world by The Wall Street Journal)* and his brother, Motley Fool CEO Tom Gardner, just revealed two brand new stock recommendations moments ago. Together, they've tripled the stock market's return over 12+ years. And while timing isn't everything, the history of Tom and David's stock picks shows that it pays to get in early on their ideas.

Click here to be among the first people to hear about David and Tom's newest stock recommendations.

*"Look Who's on Top Now" appeared in The Wall Street Journal which references Hulbert's rankings of the best performing stock picking newsletters over a 5-year period from 2008-2013.

Compare Brokers